For: | Sainamthip P, Kongphanich C, Prasongsook N, Chirapongsathorn S. Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study. World J Clin Cases 2021; 9(30): 9059-9069 [PMID: 34786388 DOI: 10.12998/wjcc.v9.i30.9059] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i30/9059.htm |
Number | Citing Articles |
1 |
Nitipon Simasingha, Wasu Tanasoontrarat, Torpong Claimon, Supatsri Sethasine. Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(5): 890-903 doi: 10.3748/wjg.v29.i5.890
|
2 |
Muhammad Zain Raza, Ali Ahmad Nadeem, Huzaifa Fayyaz Khwaja, Muhammad Omais, Hafiz Muhammad Ehsan Arshad, Musab Maqsood. Dexamethasone-Based Prophylactic Therapy for Prevention of Post-Embolization Syndrome: A Systematic Review and Meta-Analysis Assessing Its Efficacy and Influence of Dosage and Timing in Patients Undergoing Arterial Embolization. Annals of Vascular Surgery 2025; 113: 95 doi: 10.1016/j.avsg.2024.12.079
|
3 |
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association. Journal of Liver Cancer 2023; 23(2): 241 doi: 10.17998/jlc.2023.05.22
|
4 |
Oumnia Masrour, Cassandra Rayer, Baptiste Giguet, Thomas Uguen, Jeff Morcet, Caroline Jezequel, Pauline Houssel-Debry, Marc-Antoine Jegonday, Romain Moirand, Edouard Bardou-Jacquet. Dexamethasone improves clinical and biological tolerance of transcatheter arterial chemoembolization for hepatocellular carcinoma. Digestive and Liver Disease 2024; doi: 10.1016/j.dld.2024.10.024
|
5 |
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim. Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association. Korean Journal of Radiology 2023; 24(7): 606 doi: 10.3348/kjr.2023.0385
|
6 |
Thang Viet Luong, Nam Van Duc Nguyen, Linh Duy Le, Hieu Nguyen Hoang Minh, Hai Nguyen Ngoc Dang. Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization. World Journal of Gastroenterology 2024; 30(47): 4983-4990 doi: 10.3748/wjg.v30.i47.4983
|
7 |
Wassana Khuntee, Kanitha Hanprasitkam, Bualuang Sumdaengrit. Effect of music therapy on postembolization syndrome in Thai patients with hepatocellular carcinoma: A quasi-experimental crossover study. Belitung Nursing Journal 2022; 8(5): 396 doi: 10.33546/bnj.2210
|
8 |
Marco Biolato, Maurizio Pompili. Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective. World Journal of Gastroenterology 2024; 30(31): 3635-3639 doi: 10.3748/wjg.v30.i31.3635
|
9 |
M. O. Loginov, E. S. Fayzullin, D. F. Shakurov. Transradial and transfemoral access in hepatic artery chemoembolization in patients with hepatic malignancies. Russian Journal for Personalized Medicine 2024; 4(5): 421 doi: 10.18705/2782-3806-2024-4-5-421-430
|
10 |
Haohao Lu, Chuansheng Zheng, Bin Xiong, Xiangwen Xia. Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02580-8
|
11 |
Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim. Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association. Clinical and Molecular Hepatology 2023; 29(3): 521 doi: 10.3350/cmh.2023.0202
|
12 |
Wendong Feng, Wendong Cao, Cunwei Cui, Xingtao Pi, Yang Mi. Efficacy of Lipid Nanoparticle-Loaded Sorafenib Combined with Hepatic Artery Chemoembolization in the Treatment of Primary Hepatocellular Carcinoma Complicated with Microvascular Invasion. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/4996471
|